Evidence map›Paper›PMID 38916498›Full record

ArticleEmerging microbes & infections2024

"Outlaw" mutations in quasispecies of SARS-CoV-2 inhibit replication.

Philippe Colson, Jacques Fantini, Jeremy Delerce, Wahiba Bader, Anthony Levasseur, Pierre Pontarotti, Christian Devaux, Didier Raoult

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. "Fertile" Mutations in SARS-CoV-2 RNA More Frequently Occurred in Hairpin Loops That Determine Virus Evolution.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Philippe ColsonIHU Méditerranée Infection, Marseille, France.
Jacques FantiniINSERM UMR UA 16, Aix-Marseille Université, Marseille, France.
Jeremy DelerceIHU Méditerranée Infection, Marseille, France.
Wahiba BaderIHU Méditerranée Infection, Marseille, France.
Anthony LevasseurIHU Méditerranée Infection, Marseille, France.
Pierre PontarottiIHU Méditerranée Infection, Marseille, France.
Christian DevauxIHU Méditerranée Infection, Marseille, France.
Didier RaoultIHU Méditerranée Infection, Marseille, France.ORCID 0000-0002-0633-5974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evolution of SARS-CoV-2, the agent of COVID-19, has been remarkable for its high mutation potential, leading to the appearance of variants. Some mutations have never appeared in the published genomes, which represent consensus, or

Indexed as

COVID-19Genome, ViralMutationQuasispeciesSARS-CoV-2Virus ReplicationHigh-Throughput Nucleotide SequencingHumansMolecular Dynamics SimulationNasopharynxSpike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2evolutiongenomicsmutationsnext-generation sequencingquasispeciesSARS-CoV-2

Identifiers

PMID38916498
PMCPMC11207925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.